AGP Picks
View all

Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on October 30, 2026

Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
Citizens Commission on Human Rights International Warns Parents: Legal Actions in U.S. and Sweden Expose Risks of Online ADHD Diagnoses and Stimulant Promotion
Dyadic to Report Q3 2026 Financial Results and Host Conference Call on Thursday November 12, 2026
VOA National Services and On Lok Executives Examine the Future of PACE at 2026 OPEN MINDS Technology & Analytics Institute
Nathan Fielder Meets Ryan ElHosseiny: The Science Behind “The Strip Club” and “Who’s on First” in You Can See Everything
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab
SRX Global Provides Update on Balance Sheet and Share Buyback
Allsup Highlights SSDI Support For Workers With Breast Cancer During Breast Cancer Awareness Month
Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
CMMB Celebrates New Distribution Center at the Brethren Service Center with Ribbon-Cutting Ceremony
Human Expertise Meets AI: MedVirtual’s Approach to the Future of Healthcare Administration
MICRIVA Launches New Microdart Spot Care Patch for Targeted Blemished Skin Support
Boehringer Ingelheim registers Phase III trial investigating verducatib in COPD
Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
Why Kraig Labs’ Spider Silk Could Have a Future in Aerospace
NeOnc’s Ambitious Brain Cancer Plans are Setting the Stage
Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin
Akari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summit
Syndax’s Revuforj® (revumenib) Wins Prestigious 2026 Prix Galien USA Award for Best Product for Rare/Orphan Diseases

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Yemen Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.